A specific PKCα substrate or pan-PKC-substrate antibodies showed strong signal only in M-HCC cells suggesting PKCα is the candidate kinase that is inhibited by PKC inhibitors (Fig. 6a)26,27. The gene discussed is PRKCA; the disease is hepatocellular carcinoma.